Drug Type Small molecule drug |
Synonyms TR2-A |
Target |
Action antagonists |
Mechanism CCKB antagonists(Cholecystokinin B receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
RegulationOrphan Drug (United States) |
Molecular FormulaC30H32N6O5 |
InChIKeyGPEYTRIZYSZRRK-MHZLTWQESA-N |
CAS Registry1801749-44-9 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Gastroesophageal Reflux | Phase 1 | United Kingdom | - | |
| Helicobacter Infections | Phase 1 | United Kingdom | - | |
| Neuroendocrine Tumors | Phase 1 | United Kingdom | - |





